Alternative medicine

Columbia Care Completes Acquisition of Green Leaf Medical; Cements Market Leading Position in Mid-Atlantic

Friday, June 11, 2021 - 12:37pm

I am pleased to announce the completion of Columbia Cares acquisition of Green Leaf today, well ahead of our originally anticipated close, which secures our position as a national leader and the most scaled operator in the Mid-Atlantic, said Nicholas Vita, CEO of Columbia Care.

Key Points: 
  • I am pleased to announce the completion of Columbia Cares acquisition of Green Leaf today, well ahead of our originally anticipated close, which secures our position as a national leader and the most scaled operator in the Mid-Atlantic, said Nicholas Vita, CEO of Columbia Care.
  • Green Leafs proprietary gLeaf brand, cultivation and production scale, and outstanding reputation and culture are exceptional complements to the Columbia Care operational footprint in these key markets.
  • We are thrilled to welcome the Green Leaf team, led by Philip Goldberg and Kevin Goldberg, to the Columbia Care family and will strive to ensure the continued growth and customer focus that Green Leaf is known for through a thoughtful and deliberate integration.
  • After searching for the right home for our company, people and communities, it was clear that there was one organization that shared our vision and priorities Columbia Care.

Denmark CBD Regulatory Report 2021 - ResearchAndMarkets.com

Friday, June 11, 2021 - 10:32am

The "CBD Regulatory Report: Denmark" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "CBD Regulatory Report: Denmark" report has been added to ResearchAndMarkets.com's offering.
  • The Order on Narcotics defines cannabis as the plants belonging to the genus Cannabis.
  • Hemp is not specifically defined, but Danish law grants an exemption for plants of the genus Cannabis with less than 0.2% THC.
  • The Danish Agency for Agriculture uses the term "industrial hemp" when referring to the plant exempted from the narcotics law.

Electromedical Technologies Flagship Device to Be Introduced at National Chiropractic Expo

Thursday, June 10, 2021 - 5:08pm

will be hosting a booth and featuring the EMED flagship device at the upcoming Parker Seminars semi-annual national expo for chiropractors and chiropractic assistants In Orlando, Florida from June 11-13, 2021.

Key Points: 
  • will be hosting a booth and featuring the EMED flagship device at the upcoming Parker Seminars semi-annual national expo for chiropractors and chiropractic assistants In Orlando, Florida from June 11-13, 2021.
  • Presence at the expo is reflective of the Company's consistent awareness campaign and objective to on-board hundreds of new sales reps. With the U.S.
  • Parker Seminars is the leading source of continuing education for clinicians in the chiropractic field along with the opportunity to interact with the industry's leading chiropractic vendors.
  • Parker Seminars has hosted more than 430 seminars across the globe and trained over 40,000 Doctors of Chiropractic and more than 200,000 chiropractic assistants.

Generation Hemp, Inc. to Present at the USA CBD Expo in Atlanta, Georgia on Friday, June 11

Thursday, June 10, 2021 - 2:00pm

Generation Hemp, Inc., a Dallas/Fort Worth based midstream hemp company (OTCQB: GENH) today announced that the Company will attend the USA CBD Expo in Atlanta, Georgia on Friday, June 11 thru Sunday, June 13.

Key Points: 
  • Generation Hemp, Inc., a Dallas/Fort Worth based midstream hemp company (OTCQB: GENH) today announced that the Company will attend the USA CBD Expo in Atlanta, Georgia on Friday, June 11 thru Sunday, June 13.
  • The 3-day exhibition is the nations largest CBD and hemp event, including 500 of the industrys largest brands ( https://usacbdexpo.com/tickets/ ).
  • Gary C. Evans, Chairman and CEO of Generation Hemp, Inc., will present at the exhibitions Networking Event on Friday afternoon, June 11 at approximately 6:15pm EDT.
  • At the event, the Company will review and discuss the launch of its new industrial animal bedding division derived from hemp fiber.

CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Veteran Health

Thursday, June 10, 2021 - 1:15pm

Currently, CURE uses its Schedule 1 DEA license for the development of Cannabis (THC) oral film products and other psychoactive substances, and manufactures multiple commercial Cannabidiol (CBD) products in compliance with the 2018 U.S. Farm Bill.

Key Points: 
  • Currently, CURE uses its Schedule 1 DEA license for the development of Cannabis (THC) oral film products and other psychoactive substances, and manufactures multiple commercial Cannabidiol (CBD) products in compliance with the 2018 U.S. Farm Bill.
  • BRC will supply the ingredients and CURE will contribute its formulation development, regulatory, and commercial manufacturing capability, as well as support clinical studies.
  • The partnership will initiate the development of CBD and Tetrahydrocannabinol (THC) oral thin films for CUREs clinical studies targeted at advancing veteran health.
  • BRC is a specialty pharmaceutical company that holds several DEA Registrations and is pioneering the federally legal cannabis space in the USA.

HempFusion Launches Probulin Probiotics in Ireland’s Top Retailer

Thursday, June 10, 2021 - 12:05pm

HempFusion Wellness Inc. (TSX:CBD.U) (US:CBDHF) (FWB:8OO) (HempFusion or the Company), a leading health and wellness Company offering premium probiotic supplements and products containing CBD, is pleased to announce the launch of key products through its wholly owned subsidiary, Probulin Probiotics, LLC (Probulin), in Boots Ireland, the countrys leading pharmacy-led health and beauty retailer.

Key Points: 
  • HempFusion Wellness Inc. (TSX:CBD.U) (US:CBDHF) (FWB:8OO) (HempFusion or the Company), a leading health and wellness Company offering premium probiotic supplements and products containing CBD, is pleased to announce the launch of key products through its wholly owned subsidiary, Probulin Probiotics, LLC (Probulin), in Boots Ireland, the countrys leading pharmacy-led health and beauty retailer.
  • Committed to providing exceptional customer and patient care, Boots was recently recognized as the most reputable pharmacy and retailer in Ireland (* 2020 RepTrak study ).
  • HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retail locations across all 50 states of the United States and select international locations.
  • HempFusion is a board member of the US Hemp Roundtable, and HempFusions wholly-owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data.

Fluence and Proper Cannabis Partner, Introduce Advanced LED Lighting to Rising Midwestern Cannabis Market

Thursday, June 10, 2021 - 1:00pm

Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, and Proper Cannabis (Proper), a Rock Hill, Missouri-based cannabis cultivator and manufacturer, announced today the companies application of Fluences LED lighting solutions throughout Propers cultivation facility.

Key Points: 
  • Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, and Proper Cannabis (Proper), a Rock Hill, Missouri-based cannabis cultivator and manufacturer, announced today the companies application of Fluences LED lighting solutions throughout Propers cultivation facility.
  • View the full release here: https://www.businesswire.com/news/home/20210610005191/en/
    Fluences LED lighting technology illuminates cannabis crops in Propers cultivation facility.
  • Proper is headquartered in the booming Missouri cannabis market and operates a 90,000-square-foot cannabis cultivation and manufacturing facility.
  • When designing plans for its facility, Proper identified Fluences LED technology as a priority for the companys cultivation strategy.

 Miley Cyrus Joins Hims & Hers as Creative Advisor

Wednesday, June 9, 2021 - 9:13pm

Hims & Hers , the multi-specialty telehealth platform that provides modern personalized health and wellness experiences to consumers, today announced Multi-Platinum Selling Recording Artist, Songwriter and Trailblazer Miley Cyrus has joined the Company as a Creative Advisor.

Key Points: 
  • Hims & Hers , the multi-specialty telehealth platform that provides modern personalized health and wellness experiences to consumers, today announced Multi-Platinum Selling Recording Artist, Songwriter and Trailblazer Miley Cyrus has joined the Company as a Creative Advisor.
  • While I struggled a lot with my skin when I was younger, Ive learned that there isnt a one-size-fits-all skincare routine -- it needs to be personalized, commented Miley Cyrus.
  • Hims & Hers makes the entire process incredibly simple, from the initial virtual consultation to the monthly subscription of products tailored just for me.
  • For additional details on the Hims & Hers skincare offering or to learn more about the brands partnership with Miley Cyrus, please visit www.forhers.com .

Global Algal Oils Industry (2020 to 2027) - Key Market Trends and Drivers - ResearchAndMarkets.com

Wednesday, June 9, 2021 - 6:43pm

The "Algal Oils - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Algal Oils - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Dietary Supplements, one of the segments analyzed in the report, is projected to record a 14.1% CAGR and reach US$1.3 Billion by the end of the analysis period.
  • The U.S. Market is Estimated at $266 Million, While China is Forecast to Grow at 18.2% CAGR
    The Algal Oils market in the U.S. is estimated at US$266 Million in the year 2020.
  • In the global Other End-Uses segment, USA, Canada, Japan, China and Europe will drive the 11.9% CAGR estimated for this segment.

$545.7 Million Worldwide Epsom Salt Industry to 2027 - Impact of COVID-19 on the Market - ResearchAndMarkets.com

Wednesday, June 9, 2021 - 6:30pm

Amid the COVID-19 crisis, the global market for Epsom Salt estimated at US$545.7 Million in the year 2020, is projected to reach a revised size of US$656.5 Million by 2027, growing at a CAGR of 2.7% over the analysis period 2020-2027.

Key Points: 
  • Amid the COVID-19 crisis, the global market for Epsom Salt estimated at US$545.7 Million in the year 2020, is projected to reach a revised size of US$656.5 Million by 2027, growing at a CAGR of 2.7% over the analysis period 2020-2027.
  • Bath Care, one of the segments analyzed in the report, is projected to record a 2.4% CAGR and reach US$227.9 Million by the end of the analysis period.
  • The U.S. Market is Estimated at $148 Million, While China is Forecast to Grow at 4.2% CAGR
    The Epsom Salt market in the U.S. is estimated at US$148 Million in the year 2020.
  • China, the world's second largest economy, is forecast to reach a projected market size of US$124.1 Million by the year 2027 trailing a CAGR of 4.2% over the analysis period 2020 to 2027.